思微化學科技有限公司（SCIWIN LAB）於西元2017年成立 ，負責人鍾采紋為國立交通大學應用化學系博士。鍾博士曾於台耀化學股份有限公司以及錸斯藥物化學研究開發股份有限公司（2012年更名為金昇化學科技股份有限公司）研發部擔任研究員，期間完成各類小分子及大分子實驗， 有15年豐富的化學合成經驗，並擅長「雜環化合物 」、「活性標示探針(Activity-based probes )」等有機實驗， 及對於化學相關新產品的製程開發，擁有專業的技術和堅強的實力。​

      思微化學自成立以來已完成「台耀化學」、「馬偕醫院實驗室」、「交大有機實驗室」及數間「新藥開發公司」等委託案件，其成果均讓客戶滿意與信賴。

       我們相信，豐富的經驗能快速並有效地進行合成路徑選擇，最大程度地減少合成步驟以降低成本及優化每一合成步驟，提升所有產品品質， 完成客戶所需產品，並以謹慎負責的態度，堅定客戶對本公司的信賴。

​

​

SCIWIN LAB is established on 2017, the responsible person of this corporation, CAROL CHUNG, has a PhD degree from Applied Chemistry Department of National Chiao Tung University.
 

Dr. Chung has a long and distinguished career at FORMOSA LABORATORIES, INC. and RDD LAB, INC. as a researcher in R&D department, where she accomplished a variety of experiments for small and large molecule synthesis. Also, she has 15-year experience, professional technique and strength of chemical synthesis, especially synthesis of heterocyclic compounds and activity-based probes.

 

SCIWIN LAB has accomplished several cases from Formosa Laboratories, Inc., Dr. Lu Laboratory of MacKay Memorial Hospital, organic lab from National Chiao Tung University and several new drug development companies since established in 2017. We have earned customers’ satisfaction and trust.
 

SCIWIN LAB believe that we can efficiently and effectively choose the best composed ways of chemical synthesis based on our abundant experiences. We are capable of not only reducing huge compose steps of target molecule synthesis to cost down but also optimizing reaction conditions of target molecule synthesis to improve the qualities of all products and meet customers’ demands. We’ll stay cautious and responsible attitude to firm the trust from customers.

​